drugset / Trial / NCT00431145
Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
RandomizedParallel-groupOpen-labelTreatment
Summary
Aim of the study is to show additional effects of the combined therapy of niacin and statins analyzing number and function of EPCs and other stem cell populations and adiponectin as well as hsCRP levels in patients with CAD.
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niacin | Small molecule | — | — |